Figure 3

CD26 expression and CD4:CD8 ratio. (a) The proportions of CD4+CD26- T cells in Vβ positive cases (median, 70.1%; range, 2.6–96.2%); Vβ negative cases (median, 30.2%; range, 13.4–58.9%) and controls (median, 24.7%, range, 6.5–55.5%). (b) The CD4:CD8 ratio in Vβ positive cases (median, 10.5; range, 0.6–495.0); in Vβ negative cases (median, 4.1; range, 0.6–23) and in controls (median, 1.2; range, 0.07–12.9).